Financhill
Buy
85

EHC Quote, Financials, Valuation and Earnings

Last price:
$119.26
Seasonality move :
16.76%
Day range:
$115.51 - $118.21
52-week range:
$82.74 - $118.27
Dividend yield:
0.56%
P/E ratio:
24.30x
P/S ratio:
2.18x
P/B ratio:
5.49x
Volume:
604.8K
Avg. volume:
1M
1-year change:
36.47%
Market cap:
$11.9B
Revenue:
$5.4B
EPS (TTM):
$4.84

Earnings Data

Next earnings date for EHC
Aug 05
2025
Most recent earnings per share
$1.48
Beat by $0.29
(Apr 24/2025)
Consensus Estimate
$1.19
(Apr 24/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

EHC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/05/2025 Q2 $1.4B -- -- $1.21 --
04/24/2025 Q1 $1.4B $1.5B $1.48 $1.19 $0.29
02/06/2025 Q4 $1.4B $1.4B $1.18 $1.02 $0.16
10/28/2024 Q3 $1.3B $1.4B $1.06 $0.94 $0.12
08/05/2024 Q2 $1.3B $1.3B $1.12 $1.01 $0.11
04/25/2024 Q1 $1.3B $1.3B $1.10 $0.94 $0.16
02/07/2024 Q4 $1.2B $1.2B $0.86 $0.82 $0.04
10/26/2023 Q3 $1.2B $1.2B $0.84 $0.77 $0.07
08/01/2023 Q2 $1.2B $1.2B $0.90 $0.74 $0.16
04/27/2023 Q1 $1.1B $1.2B $0.87 $0.71 $0.16
02/07/2023 Q4 -- $1.1B $0.89 -- --
10/26/2022 Q3 -- $1.1B $0.45 -- --
08/01/2022 Q2 -- $1.1B $0.49 -- --
04/27/2022 Q1 -- $1.1B $0.87 -- --
02/01/2022 Q4 -- $1B $0.91 -- --
10/27/2021 Q3 -- $1B $1.00 -- --
07/27/2021 Q2 -- $1.3B $1.13 -- --
04/27/2021 Q1 -- $1.2B $1.07 -- --
01/26/2021 Q4 -- $136.3M $0.86 -- --
10/28/2020 Q3 -- $1.2B $0.78 -- --
07/27/2020 Q2 -- $1.1B $0.34 -- --
04/28/2020 Q1 -- $1.2B $0.87 -- --
02/06/2020 Q4 -- $1.2B $0.68 -- --
10/28/2019 Q3 -- $1.2B $0.98 -- --
07/29/2019 Q2 -- $1.1B $0.92 -- --
04/25/2019 Q1 -- $1.1B $1.03 -- --
02/07/2019 Q4 -- $1.1B $0.28 -- --
10/29/2018 Q3 -- $1.1B $0.89 -- --
07/25/2018 Q2 -- $1.1B $0.92 -- --
04/26/2018 Q1 -- $1B $0.84 -- --
02/26/2018 Q4 -- $1B $0.61 -- --
10/26/2017 Q3 -- $981.6M $0.67 -- --
07/31/2017 Q2 -- $966.4M $0.70 -- --
04/27/2017 Q1 -- $957.1M $0.70 -- --
02/21/2017 Q4 -- $932M $0.68 -- --
10/27/2016 Q3 -- $912M $0.64 -- --
07/28/2016 Q2 -- $905.3M $0.65 -- --
04/26/2016 Q1 -- $893.3M $0.61 -- --
02/23/2016 Q4 -- $865.3M $0.49 -- --
10/28/2015 Q3 -- $767.9M $0.52 -- --
07/30/2015 Q2 -- $753.5M $0.45 -- --

Encompass Health Earnings Questions

  • How Much did Encompass Health Generate in Revenue Last Quarter?

    Encompass Health reported $1.5B worth of top line sales in its most recent quarter.

  • Did Encompass Health Beat Earnings Last Quarter?

    Encompass Health announced earnings per share of $1.48 which represents a beat of analyst forecast a $1.19 per share.

  • Is Encompass Health Profitable?

    Encompass Health reported $630.9M that represents $6.18 per share over the last quarter.

  • What is the Analyst Consensus for Encompass Health EPS Next Year?

    Encompass Health's earnings are forecast to grow from $4.46 per share to $4.30 per share next year representing an increase of 12.53%.

  • When is Encompass Health's Earnings Date?

    Encompass Health's next earnings date is August 5, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Which Stocks Are Recession-Proof?
Which Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Is Gartner a Safe Stock to Own?
Is Gartner a Safe Stock to Own?

Gartner (NYSE:IT) is among the world’s largest consulting, research and…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 44x

Alerts

Buy
57
RGC alert for May 14

Regencell Bioscience Holdings [RGC] is up 8.9% over the past day.

Buy
54
HALO alert for May 14

Halozyme Therapeutics [HALO] is down 4.72% over the past day.

Buy
91
COIN alert for May 14

Coinbase Global [COIN] is up 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock